HIV prevention in developed countries

TJ Coates, P Aggleton, F Gutzwiller, D Des Jarlais… - The Lancet, 1996 - thelancet.com
HIV prevention in developed countries is marked by impressive successes and dismal
failures. The successes point the way to what works; the failures highlight obstacles that …

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

V Simon, DD Ho, QA Karim - The Lancet, 2006 - thelancet.com
The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries
and regions of the world, and is undoubtedly the defining public-health crisis of our time …

[HTML][HTML] Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …

JW Eaton, NA Menzies, J Stover… - The Lancet Global …, 2014 - thelancet.com
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-
positive adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …

Call to action: how can the US Ending the HIV Epidemic initiative succeed?

C Beyrer, AA Adimora, SL Hodder, E Hopkins, G Millett… - The Lancet, 2021 - thelancet.com
With more than 1· 2 million people living with HIV in the USA, a complex epidemic across the
large and diverse country, and a fragmented health-care system marked by widening health …

The WHO public health approach to HIV treatment and care: looking back and looking ahead

N Ford, A Ball, R Baggaley, M Vitoria… - The Lancet Infectious …, 2018 - thelancet.com
In 2006, WHO set forth its vision for a public health approach to delivering antiretroviral
therapy. This approach has been broadly adopted in resource-poor settings and has …

The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study

B Nosyk, JSG Montaner, G Colley, VD Lima… - The Lancet infectious …, 2014 - thelancet.com
Background The cascade of HIV care has become a focal point for implementation efforts to
maximise the individual and public health benefits of antiretroviral therapy. We aimed to …

[PDF][PDF] The effectiveness of HIV prevention and the epidemiological context

NC Grassly, GP Garnett… - Bulletin of the World …, 2001 - SciELO Public Health
Planning an intervention to prevent infections with the human immunodeficiency virus (HIV)
should be guided by local epidemiological and socioeconomic conditions. The …

HIV-1 epidemic control—insights from test-and-treat trials

SS Abdool Karim - New England Journal of Medicine, 2019 - Mass Medical Soc
Debate ensued when mathematical models1 predicted that universal testing and treatment
could achieve epidemic control within a few years in a high-burden setting. However, the …

[HTML][HTML] Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study

JAC Hontelez, MN Lurie, T Bärnighausen… - PLoS …, 2013 - journals.plos.org
Background Expanded access to antiretroviral therapy (ART) using universal test and treat
(UTT) has been suggested as a strategy to eliminate HIV in South Africa within 7 y based on …

[HTML][HTML] HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa

JW Eaton, LF Johnson, JA Salomon… - PLoS …, 2012 - journals.plos.org
Background Many mathematical models have investigated the impact of expanding access
to antiretroviral therapy (ART) on new HIV infections. Comparing results and conclusions …